crv 101
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 3, 2019 (NCT03820414)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human herpesvirus 3Immunity, active
Human herpesvirus 3 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03820414 | Phase 1 | Jan 3, 2019 | Curevo Inc, Green Cross Corporation, Immune Design, Mogam Biotechnology Research Institute, The Center for Pharmaceutical Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Curevo Inc | For profit | 1 | 1 | 1 | 2019 |
| Green Cross Corporation | For profit | 1 | 0 | 1 | 2019 |
| Immune Design | For profit | 1 | 0 | 1 | 2019 |
| Mogam Biotechnology Research Institute | Academic/Hospital | 1 | 0 | 1 | 2019 |
| The Center for Pharmaceutical Research | Academic/Hospital | 1 | 0 | 1 | 2019 |
5 organizations
Page 1 / 1